Sanara MedTech (SMTI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting called to order by the CEO, held virtually to facilitate shareholder participation.
Rules of procedure posted online; participants asked to follow them.
Chairman and secretary roles assigned; inspector of election appointed.
Agenda included election of directors, ratification of auditor, advisory votes on executive compensation, and other business.
Board and executive committee updates
Current board members introduced at the start of the meeting.
Nine director nominees listed for election, each to serve until the 2027 annual meeting.
Shareholder proposals
Shareholders voted on four main proposals: election of directors, ratification of auditor, approval of executive compensation, and frequency of future advisory votes on compensation.
Latest events from Sanara MedTech
- Q1 2026 revenue rose 19% to $27.8M, with net income of $0.4M and strong gross margin of 93%.SMTI
Q1 202612 May 2026 - Focused on surgical wound care, the company projects strong growth and new product launches.SMTI
TD Cowen 46th Annual Health Care Conference12 May 2026 - New Lead Independent Director and Compensation Committee chair appointed, with updated compensation.SMTI
Proxy filing17 Apr 2026 - Annual Meeting to vote on directors, auditor, and executive pay, with board recommendations.SMTI
Proxy filing17 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and governance matters.SMTI
Proxy filing17 Apr 2026 - Record 2025 revenue and margin, with 2026 growth outlook driven by surgical and market expansion.SMTI
Q4 202524 Mar 2026 - All agenda items, including director elections and governance changes, were approved.SMTI
AGM 20242 Feb 2026 - Q2 2024 revenue up 28% to $20.2M; gross margin 90%; net loss $3.5M; THP launch in 2025.SMTI
Q2 20241 Feb 2026 - Record Q3 revenue and EBITDA growth, but higher costs led to a larger net loss.SMTI
Q3 202414 Jan 2026